Agensys (Drug conjugate linker-toxin & CD3-based bispecific technologies) is Buildings and Property in United States that focus on based bispecific technology business. They cover business area such as Agensys asset, Santa Monica, California.
-
Based Bispecific Technology
-
1800 Stewart Street
Santa Monica, CA 90404
United States
Private
Agensys assetSanta MonicaCalifornia
* We use standard office opening hours in near Agensys (Drug conjugate linker-toxin & CD3-based bispecific technologies)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Agensys (Drug Conjugate Linker-toxin & CD3-based Bispecific Technologies) is Buildings and Property business from United States that founded in - ( years old in ), Agensys (Drug conjugate linker-toxin & CD3-based bispecific technologies) business is focusing on Based Bispecific Technology.
Agensys (Drug conjugate linker-toxin & CD3-based bispecific technologies) headquarter office and corporate office address is located in 1800 Stewart Street Santa Monica, CA 90404 United States.
Agensys (Drug conjugate linker-toxin & CD3-based bispecific technologies) was founded in United States.
In , Agensys (Drug conjugate linker-toxin & CD3-based bispecific technologies) is currently focus on based bispecific technology sector.
Above is snippet of Google Trends for "based bispecific technology" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Agensys (Drug conjugate linker-toxin & CD3-based bispecific technologies), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
